Study of PROMIS-29 v2.1 Survey to Assess Physical and Mental Health in Postpartum Women After Vaginal or Cesarean Delivery

What this Trial Is About

This research aims to evaluate the reliability and validity of the PROMIS-29 v2.1 survey for assessing physical and mental health in postpartum women. The PROMIS-29 survey screens for pain, mood impairments, physical function, and daily living activities. Although validated in general populations, it has not yet been studied specifically in women after childbirth. The study is observational and focuses on postpartum women following vaginal or cesarean delivery. Participants will complete virtual surveys at four time points immediately after delivery 0 weeks, and then at 2, 6, and 12 weeks postpartum. The survey data from PROMIS-29 will be compared to established quality of life measures, including the WHOQoLBREF and EQ-5D-3L1 surveys. Two groups will be observed women who had vaginal deliveries with neuraxial labor analgesia and those who underwent scheduled cesarean deliveries with neuraxial anesthesia. Throughout the study, participants will provide patient-reported outcomes via online surveys at the specified intervals. Researchers will evaluate the statistical validity and reliability of the PROMIS-29 tool by comparing it with other quality of life assessments. The primary outcomes include scores from PROMIS-29, WHOQoLBREF, and EQ-5D-3L1 surveys collected at each time point. The study will continue until July 2026, involving monitoring of physical and psychological well-being during the first 12 weeks after childbirth.

Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women